T1	Intervention 490 620	6 cycles of chemotherapy with intravenous administration of paclitaxel (175 mg/m2, on D3) and epirubicin (60 mg/m2, on Dl and D2).
T2	Intervention 737 827	G-CSF was used in a dose of 3 microg/kg on D5-D9 during each cycle in the dose-dense group
T3	Intervention 621 735	The dose-dense group had repeated treatment every two weeks, while the regular group repeated it every three weeks
